pNPS-DHA
pNPS-DHA (Compound 19) is an orally active DHA-ethanolamide (DHEA) derivative that has antiallergic activity. pNPS-DHA inhibits IgE-dependent passive cutaneous anaphylaxis (PCA) reaction in mice. pNPS-DHA has anti-degranulating activity in RBL-2H3 mast cells with an IC50 of 15 μM.
For research use only. We do not sell to patients.
- CAS No.: 2454246-25-2
- Formula: C28H36N2O5S
- Molecular Weight:512.66
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
- Protocols
- Purity & Documentation
- References
-
Help & FAQs
-
HY-W009123
ErucamideTMEM19 Ligand, T3SS Inhibitor -
HY-N0691
SchisandrinAutophagy Inducer -
HY-130311
2-Linoleoyl glycerolCB1 Receptor Agonist -
HY-120963
N-Oleoyl Taurine -
HY-32345
ElocalcitolVDR Agonist -
HY-W009123R
Erucamide (Standard)Bioactive Fluid Regulator -
HY-N0691R
Schisandrin (Standard)Autophagy Inducer -
HY-128127
NAEPALPA Receptor Agonist -
HY-157833
Heptadecanoyl ethanolamideEndogenous Cannabinoid -
HY-120962
N-Arachidonoyl TaurineTRPV Activator -
HY-124001
N-Docosanoyl taurineLipoamino Acids -
HY-126720
N-Lignoceroyl Taurine
Biological Activity
Description
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| RBL-2H3 | IC50 |
15 μM
Compound: 59
|
Antiallergic activity in rat RBL2H3 cells assessed as inhibition of DNP-HSA-mediated degranulation by measuring decrease in beta-hexosaminidase activity preincubated for 30 mins followed by DNP-HSA stimulation and measured after 30 mins by 4-nitrophenyl 2
Antiallergic activity in rat RBL2H3 cells assessed as inhibition of DNP-HSA-mediated degranulation by measuring decrease in beta-hexosaminidase activity preincubated for 30 mins followed by DNP-HSA stimulation and measured after 30 mins by 4-nitrophenyl 2
|
[PMID: 31618024] |
| Sf9 | IC50 |
36 μM
Compound: 59
|
Inhibition of human FAAH expressed in baculovirus infected Sf9 cells using N-(6-methoxypyridin-3-yl)octanamide as substrate measured for 15 mins by fluorescence based assay
Inhibition of human FAAH expressed in baculovirus infected Sf9 cells using N-(6-methoxypyridin-3-yl)octanamide as substrate measured for 15 mins by fluorescence based assay
|
[PMID: 31618024] |
Chemical Information
-
CAS No. 2454246-25-2
-
Molecular Weight 512.66
-
Formula C28H36N2O5S
-
SMILES
CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(NS(=O)(C1=CC=C([N+]([O-])=O)C=C1)=O)=O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
pNPS-DHA Related Classifications
HY-139247 Related Classifications
Powered by Bioz